Wednesday's top analyst upgrades and downgrades included Affirm, Bausch + Lomb, Electronic Arts, EOG Resources, Foot Locker, Ford, GoodRx, Goodyear Tire, Healthcare Trust of America, Simon Property, Tesla and Unity Software.
Tuesday’s additional top analyst upgrades and downgrades were on Affirm, Edison International, GoodRx, LivePerson, Palantir Technologies, Progressive, Upstart and more.
Friday afternoon's top analyst upgrades and downgrades included Affirm, AstraZeneca, Block, CVS, Kellogg and more.
After markets close Thursday, quarterly results are due from these four growth stocks.
Friday afternoon's top analyst upgrades and downgrades included Apple, Gilead, Goldman Sachs, Kroger, Raymond James, and more.
Monday afternoon's top analyst upgrades and downgrades included Affirm, Charter Communications, Discover Financial Services, Fox, Newmont, PPG, Splunk and Victoria’s Secret.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Affirm, Bank of New York Mellon, Cloudflare, DoorDash, Ford, Juniper Networks, Truist Financial and Unilever.
Thursday's top analyst upgrades and downgrades included AT&T, Abbott Laboratories, Advanced Micro Devices, Affirm, Canopy Growth, Cleanspark, Eli Lilly, ESS Tech, Global Payments and Luminar Technologies.
Stocks took a big hit on Thursday and were indicating a lower start to Friday's trading as well.
Monday’s top analyst upgrades and downgrades included Affirm, BlackRock, Deere, Dick's Sporting Goods, Dollar Tree, Intercontinental Exchange, Mastercard, Merck, Nordstrom, Petrobras and Pure Storage.
Here's a look at Walt Disney and three other companies due to post quarterly results after the markets close on Wednesday.
Friday afternoon's analyst upgrades and downgrades included Affirm, Crown Castle, Humana, Ingersoll Rand and Palo Alto Networks.
Buy now, pay later has become a hotspot for expansion. The latest deal between Amazon and Affirm is just the latest example. Here is what analysts have to say about the deal.
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Tuesday, including Affirm, BioCryst Pharmaceuticals, Exxon Mobile, First Solar and Tesla.
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
